Literature DB >> 2829575

RNA recombination of coronavirus.

J G Keck1, S Makino, L H Soe, J O Fleming, S A Stohlman, M M Lai.   

Abstract

We have previously shown that Mouse hepatitis virus (MHV) can undergo RNA-RNA recombination at a very high frequency (S. Makino, et al., J. Virol. 57, 729-737, 1986). To better define the mechanism of RNA recombination, we have performed additional crosses involving different MHV strains. We have obtained recombinant viruses with multiple cross-overs. The isolation of such recombinants further indicates the high frequency of coronavirus RNA recombination. By using cell fusion as a selection marker, we have also obtained recombinants between MHV-2 and A59 strains. Some of these recombinants have cross-overs in the 3'-end genes of the genome, thus demonstrating that recombination could occur along the entire genome. Finally, we have obtained recombinants by selecting with neutralizing monoclonal antibodies. These recombinants have cross-overs within gene C which encodes the peplomer protein. The genetic structure of these recombinants allowed us to determine the important domains of the peplomer proteins.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2829575     DOI: 10.1007/978-1-4684-1280-2_11

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  13 in total

1.  Noncytopathogenic pestivirus strains generated by nonhomologous RNA recombination: alterations in the NS4A/NS4B coding region.

Authors:  Andreas Gallei; Michaela Orlich; Heinz-Juergen Thiel; Paul Becher
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

2.  Virus strain specificity of challenge immunity to coronavirus.

Authors:  S W Barthold; A L Smith
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

3.  Feline aminopeptidase N serves as a receptor for feline, canine, porcine, and human coronaviruses in serogroup I.

Authors:  D B Tresnan; R Levis; K V Holmes
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

Review 4.  Update on treatment and preventive interventions against COVID-19: an overview of potential pharmacological agents and vaccines.

Authors:  Yinan Xiao; Hanyue Xu; Wen Guo; Yunuo Zhao; Yuling Luo; Ming Wang; Zhiyao He; Zhenyu Ding; Jiyan Liu; Lei Deng; Fushen Sha; Xuelei Ma
Journal:  Mol Biomed       Date:  2020-12-03

5.  Epidemiology and Etiopathogeny of COVID-19.

Authors:  Modesto Leite Rolim Neto; Claúdio Gleidiston Lima da Silva; Maria do Socorro Vieira Dos Santos; Estelita Lima Cândido; Marcos Antônio Pereira de Lima; Sally de França Lacerda Pinheiro; Roberto Flávio Fontenelle Pinheiro Junior; Claudener Souza Teixeira; Sávio Samuel Feitosa Machado; Luiz Fellipe Gonçalves Pinheiro; Grecia Oliveira de Sousa; Lívia Maria Angelo Galvão; Karla Graziely Soares Gomes; Karina Alves Medeiros; Luana Araújo Diniz; Ítalo Goncalves Pita de Oliveira; Jéssica Rayanne Pereira Santana; Maria Aline Barroso Rocha; Irving Araújo Damasceno; Thiago Lima Cordeiro; Wendell da Silva Sales
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

6.  Evolution of SARS-CoV-2 in Spain during the First Two Years of the Pandemic: Circulating Variants, Amino Acid Conservation, and Genetic Variability in Structural, Non-Structural, and Accessory Proteins.

Authors:  Paloma Troyano-Hernáez; Roberto Reinosa; África Holguín
Journal:  Int J Mol Sci       Date:  2022-06-07       Impact factor: 6.208

Review 7.  Coronaviruses: An Updated Overview of Their Replication and Pathogenesis.

Authors:  Yuhang Wang; Matthew Grunewald; Stanley Perlman
Journal:  Methods Mol Biol       Date:  2020

Review 8.  Coronaviruses: an overview of their replication and pathogenesis.

Authors:  Anthony R Fehr; Stanley Perlman
Journal:  Methods Mol Biol       Date:  2015

Review 9.  Known drugs and small molecules in the battle for COVID-19 treatment.

Authors:  Alexios A Panoutsopoulos
Journal:  Genes Dis       Date:  2020-06-20

Review 10.  Conjunctivitis as a Sentinel of SARS-CoV-2 Infection: a Need of Revision for Mild Symptoms.

Authors:  Alexios A Panoutsopoulos
Journal:  SN Compr Clin Med       Date:  2020-06-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.